Silibinin Suppresses Tumor Cell-Intrinsic Resistance to Nintedanib and Enhances Its Clinical Activity in Lung Cancer
Cancers (Basel). 2021 Aug 19;13(16):4168. doi: 10.3390/cancers13164168.ABSTRACTThe…
Metformin Is a Pyridoxal-5′-phosphate (PLP)-Competitive Inhibitor of SHMT2
Cancers (Basel). 2021 Aug 9;13(16):4009. doi: 10.3390/cancers13164009.ABSTRACTThe…
Altered regulation of BRCA1 exon 11 splicing is associated with breast cancer risk in carriers of BRCA1 pathogenic variants
Hum Mutat. 2021 Nov;42(11):1488-1502. doi: 10.1002/humu.24276.…
ASTCT, CIBMTR, and EBMT clinical practice recommendations for transplant and cellular therapies in mantle cell lymphoma
Bone Marrow Transplant. 2021 Dec;56(12):2911-2921. doi: 10.1038/s41409-021-01288-9.…
Histamine signaling and metabolism identify potential biomarkers and therapies for lymphangioleiomyomatosis
EMBO Mol Med. 2021 Sep 7;13(9):e13929. doi: 10.15252/emmm.202113929.…
Hyaluronidase expression within tumors increases virotherapy efficacy and T cell accumulation
Mol Ther Oncolytics. 2021 May 29;22:27-35. doi: 10.1016/j.omto.2021.05.009.…
Histamine signaling and metabolism identify potential biomarkers and therapies for lymphangioleiomyomatosis
EMBO Mol Med. 2021 Sep 7;13(9):e13929. doi: 10.15252/emmm.202113929.…
Validation of the International Myeloma Working Group standard response criteria in the PETHEMA/GEM2012MENOS65 study: are these times of change?
Blood. 2021 Nov 11;138(19):1901-1905. doi: 10.1182/blood.2021012319.NO…
Identification of different side effects between PARP inhibitors and their polypharmacological multi-target rationale
Br J Clin Pharmacol. 2022 Feb;88(2):742-752. doi: 10.1111/bcp.15015.…
Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores
J Natl Cancer Inst. 2022 Jan 11;114(1):109-122. doi: 10.1093/jnci/djab147.ABSTRACTBACKGROUND:…
Transgene codon usage drives viral fitness and therapeutic efficacy in oncolytic adenoviruses
NAR Cancer. 2021 Apr 26;3(2):zcab015. doi: 10.1093/narcan/zcab015.…
Heterogeneity and Cancer-Related Features in Lymphangioleiomyomatosis Cells and Tissue
Mol Cancer Res. 2021 Nov;19(11):1840-1853. doi: 10.1158/1541-7786.MCR-21-0220.…
